Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trabeculectomy with versus without intravitreal bevacizumab in diabetic patients
IRCT2014102219206N3Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Oct 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of bevacizumab in Glaucoma and diabetic eye disease (2 arms), sponsored by Iran University of Medical Sciences. Started Oct 2014; status: completed.
02
Drugs
bevacizumab
03
Conditions
Glaucomadiabetic eye disease
Beyond the preview
Go deeper on IRCT2014102219206N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014102219206N3.